{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:58:37Z","timestamp":1770983917425,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Il Farmaco"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.farmac.2004.03.008","type":"journal-article","created":{"date-parts":[[2004,6,2]],"date-time":"2004-06-02T17:45:54Z","timestamp":1086198354000},"page":"743-746","source":"Crossref","is-referenced-by-count":4,"title":["Enantiomeric separation of cizolirtine and metabolites on amylose tris (3,5-dimethylphenyl carbamate) chiral stationary phase"],"prefix":"10.1016","volume":"59","author":[{"given":"Hassan Y.","family":"Aboul-Enein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.farmac.2004.03.008_BIB1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1358\/mf.2000.22.4.584453","article-title":"Pharmacology cizolirtine: a new analgesic agent","volume":"22","author":"Alvarez","year":"2000","journal-title":"Method. Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.farmac.2004.03.008_BIB2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0731-7085(91)80065-H","article-title":"Validation of GC method to measure a new analgesic (E-4018) in biological samples","volume":"9","author":"Caturla","year":"1991","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.farmac.2004.03.008_BIB3","first-page":"1","article-title":"Chirality and drugs hazards, The Impact of Stereochemistry on Drug Development","author":"Aboul-Enein","year":"1997"},{"key":"10.1016\/j.farmac.2004.03.008_BIB4","doi-asserted-by":"crossref","first-page":"646A","DOI":"10.1021\/ac00083a002","article-title":"Chiral separation","volume":"66","author":"Novotny","year":"1994","journal-title":"Anal. Chem"},{"key":"10.1016\/j.farmac.2004.03.008_BIB5","doi-asserted-by":"crossref","first-page":"632A","DOI":"10.1021\/ac00083a001","article-title":"Chiral media for capillary electrophoresis: review","volume":"66","author":"Ward","year":"1994","journal-title":"Anal. Chem."},{"key":"10.1016\/j.farmac.2004.03.008_BIB6","series-title":"FDA Policy Statements for the Development of New Stereoisomeric Drugs","year":"1992"},{"key":"10.1016\/j.farmac.2004.03.008_BIB7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1520-636X(1999)11:1<63::AID-CHIR11>3.0.CO;2-K","article-title":"Optical resolution of and enantiomeric purity determination of the analgesic cizolirtine","volume":"11","author":"Torrens","year":"1999","journal-title":"J. Redondo. Chirality"},{"key":"10.1016\/j.farmac.2004.03.008_BIB8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/(SICI)1520-636X(1999)11:9<694::AID-CHIR5>3.0.CO;2-W","article-title":"Chiral discrimination of the analgesic cizolirtine by using cyclodextrins: a 1H NMR study on the solution structures of their host\u2013guest complexes","volume":"11","author":"Redondo","year":"1999","journal-title":"Chirality"},{"key":"10.1016\/j.farmac.2004.03.008_BIB9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0021-9673(02)00017-1","article-title":"Simultaneous separation of the enantiomers of cizolirtine and its degradation products by capillary electrophoresis","volume":"A 950","author":"Gomez-Gomar","year":"2002","journal-title":"J. Chromatogr"},{"key":"10.1016\/j.farmac.2004.03.008_BIB10","series-title":"Chiral Separations by Liquid Chromatography and Related Technologies","author":"Aboul-Enein","year":"2003"},{"key":"10.1016\/j.farmac.2004.03.008_BIB11","series-title":"Chromatographic Enantioseparation: Methods and Applications","author":"Allenmark","year":"1991"},{"key":"10.1016\/j.farmac.2004.03.008_BIB12","article-title":"A Practical Approach to Chiral Separations by Liquid Chromatography","author":"Subramanian","year":"1994","journal-title":"VCH Verlagsgesellschaft mbH, Weinheim"},{"key":"10.1016\/j.farmac.2004.03.008_BIB13","series-title":"The Impact of Stereochemistry on Drug Development and Use","author":"Aboul-Enein","year":"1997"},{"key":"10.1016\/j.farmac.2004.03.008_BIB14","series-title":"Chiral Chromatography","author":"Beesley","year":"1998"},{"key":"10.1016\/j.farmac.2004.03.008_BIB15","first-page":"90","volume":"162","author":"Ronden","year":"1993"},{"key":"10.1016\/j.farmac.2004.03.008_BIB16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0021-9673(01)90318-8","article-title":"Resolution of enantiomeric amides on a cellulose-based chiral stationary phase. Steric and electronic effects","volume":"358","author":"Wainer","year":"1986","journal-title":"J. Chromatogr"},{"key":"10.1016\/j.farmac.2004.03.008_BIB17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0021-9673(01)94466-8","article-title":"Resolution of enantiomeric amides on a cellulose tribenzoate chiral stationary phase. Mobile phase modifier effects on retention and stereo-selectivity","volume":"388","author":"Wainer","year":"1987","journal-title":"J. Chromatogr"},{"key":"10.1016\/j.farmac.2004.03.008_BIB18","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1246\/bcsj.72.1815","article-title":"Computational studies on chiral discrimination mechanism of phenylcarbamate derivatives of cellulose","volume":"72","author":"Yamamoto","year":"1999","journal-title":"Bull. Chem. Soc. Jpn"}],"container-title":["Il Farmaco"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014827X04000916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014827X04000916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T15:29:53Z","timestamp":1549553393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014827X04000916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0014827X04000916"],"URL":"https:\/\/doi.org\/10.1016\/j.farmac.2004.03.008","relation":{},"ISSN":["0014-827X"],"issn-type":[{"value":"0014-827X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}